ArticleScientific reports2025
Erythrocyte membrane lipid profile in children and adolescents with metabolic dysfunction-associated steatotic liver disease and insulin resistance: a preliminary study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In recent years, the prevalence of obesity in children has increased rapidly, resulting in insulin resistance (IR) and metabolic dysfunction-associated steatotic liver disease (MASLD) being diagnosed with increasing frequency. The main objective of this study was to evaluate the phospholipids and fatty acids of erythrocyte cell membranes in overweight and obese children. Subsequently, patients with MASLD and IR were selected. The structural properties of the erythrocyte membrane were determined in the red blood cells using the gas-liquid chromatography method. This prospective analysis included a cohort of 68 children, among whom IR was identified in 72.06% and MASLD in 57.35% of cases. No significant differences in membrane lipid profile were observed between MASLD and non-MASLD groups. Sphingomyelin (SM) polyunsaturated fatty acids (PUFA), SM n-6 PUFA, and SM n-6/n-3 PUFA values were significantly higher in the group with IR. The group with homeostasis model assessment of insulin resistance > 2.5 also had higher values of phosphatidylethanolamine (PE) PUFA, PE n-3 PUFA and PE n-6 PUFA. These findings suggest that insulin resistance may be associated with specific changes in erythrocyte membrane lipid composition. Further studies on a larger group of patients are needed to confirm this association.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.